ResearcherXuzhou Medical CollegeNo recent work listed

Jin Bai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1524-7893; OpenAlex author ID A5072548035. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer. Last author DOI 10.1007/s10637-019-00785-5 ↗
Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma. Co-author DOI 10.7314/apjcp.2015.16.7.2719 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Minghua Zhu · 1 shared paper, 2020 · strength 0.12
- Paper Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer. DOI 10.1007/s10637-019-00785-5 ↗
Qing-Hua Liu · 1 shared paper, 2020 · strength 0.12
- Paper Reduced expression of annexin A1 promotes gemcitabine and 5-fluorouracil drug resistance of human pancreatic cancer. DOI 10.1007/s10637-019-00785-5 ↗
Jun-Nian Zheng · 1 shared paper, 2015 · strength 0.07
- Paper Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma. DOI 10.7314/apjcp.2015.16.7.2719 ↗
Qinghua Liu · 1 shared paper, 2015 · strength 0.07
- Paper Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma. DOI 10.7314/apjcp.2015.16.7.2719 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.